HomeAI · summaries
Storia in 2 fonti
Natera Eyes Massive New Cancer Market; In Buy Zone With Q2 Report Due
Cancer test name Natera stock is in a buy zone above a cup base ahead of second-quarter results due Thursday.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
investors.com
Natera Eyes Massive New Cancer Market; In Buy Zone With Q2 Report Due
Cancer test name Natera stock is in a buy zone above a cup base ahead of second-quarter results due Thursday.
- ·
What To Know About This IBD 50 Stock's 'Blowout' Quarter
Natera stock surged Friday after reporting "blowout volume" for its cancer-detecting blood test, Signatera.
